{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113676","form_type":"8-K","ticker":"CVRX","cik":"0001235912","company_name":"CVRx, Inc.","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.913076+00:00","generated_at":"2026-05-30T05:48:28.339334+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CMS assigns Barostim to APC 1580; payment ~$45,000 continues in 2025","bullets":["Centers for Medicare and Medicaid Services assigned Barostim procedure to New Technology APC 1580.","APC payment of approximately $45,000 will continue in 2025 per Medicare OPPS final rule.","Announcement on November 4, 2024, confirms favorable reimbursement for CVRx's Barostim therapy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113676","json":"https://secwatch.observer/filing/0001104659-24-113676.json","markdown":"https://secwatch.observer/filing/0001104659-24-113676.md","text":"https://secwatch.observer/filing/0001104659-24-113676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1235912/000110465924113676/0001104659-24-113676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1235912/000110465924113676/tm2427376d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:48:28.339334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}